These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6304560)

  • 1. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression.
    Sulser F; Janowsky AJ; Okada F; Manier DH; Mobley PL
    Neuropharmacology; 1983 Mar; 22(3 Spec No):425-31. PubMed ID: 6304560
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
    Sulser F
    J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.
    Sulser F; Gillespie DD; Mishra R; Manier DH
    Ann N Y Acad Sci; 1984; 430():91-101. PubMed ID: 6331266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting depression.
    Campbell IC; Marsden K; Powell JF
    Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
    [No Abstract]   [Full Text] [Related]  

  • 5. Independent evaluation of new drugs.
    Ball CJ
    Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
    Charney DS; Menkes DB; Heninger GR
    Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta adrenergic receptor function in depression and the effect of antidepressant drugs.
    Pandey GN; Sudershan P; Davis JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():66-79. PubMed ID: 2984893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and adaptation of central norepinephrine receptor systems: modification by antidepressant treatments.
    Sulser F
    Psychiatr J Univ Ott; 1982 Sep; 7(3):196-203. PubMed ID: 6294716
    [No Abstract]   [Full Text] [Related]  

  • 9. Amphetamine normalizes reserpine-induced supersensitivity of the noradrenaline receptor coupled adenylate cyclase system in brain.
    Gillespie DD; Manier DH; Sulser F
    J Pharm Pharmacol; 1980 Jul; 32(7):503-4. PubMed ID: 6105190
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine dysfunction in depression.
    Anand A; Charney DS
    J Clin Psychiatry; 2000; 61 Suppl 10():16-24. PubMed ID: 10910013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant treatments and regulation of norepinephrine-receptor-coupled adenylate cyclase systems in brain.
    Sulser F
    Adv Biochem Psychopharmacol; 1984; 39():249-61. PubMed ID: 6087628
    [No Abstract]   [Full Text] [Related]  

  • 14. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J
    Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of receptor-mediated cyclic AMP production in brain.
    Duman RS; Enna SJ
    Neuropharmacology; 1987 Jul; 26(7B):981-6. PubMed ID: 2821437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of antidepressant drugs.
    Sulser F; Vetulani J; Mobley PL
    Biochem Pharmacol; 1978 Feb; 27(3):257-61. PubMed ID: 202286
    [No Abstract]   [Full Text] [Related]  

  • 17. Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.
    Lerer B; Ebstein RP; Belmaker RH
    Psychopharmacology (Berl); 1981; 75(2):169-72. PubMed ID: 6275441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine.
    Mishra R; Janowsky A; Sulser F
    Eur J Pharmacol; 1979 Dec; 60(4):379-82. PubMed ID: 316774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of amine hypotheses in depressive disorders].
    Fritze J; Deckert J; Lanczik M; Strik W; Struck M; Wodarz N
    Nervenarzt; 1992 Jan; 63(1):3-13. PubMed ID: 1314964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonergic input in the regulation of the beta-adrenergic receptor-coupled adenylate cyclase system.
    Janowsky A; Okada F; Manier DH; Applegate CD; Sulser F; Steranka LR
    Science; 1982 Nov; 218(4575):900-1. PubMed ID: 6291152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.